Journal profile · TRANSPLANTATION

Transplant Research and Risk Management

ISSN 1179-1616 · Dove Medical Press · United Kingdom

Transplant Research and Risk Management: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 1,806; review about 16 weeks (community reports); 2 articles a year; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category
Review timeabout 16 weeksCommunity average; too few article dates (1)
APCUSD 1,806Fully open access
Acceptance—No reports yet
Articles per year2LetPub annual count

Scope

Aims, scope and focus

Transplant Research and Risk Management is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes and Organ Donation and Transplantation, together about 47.9% of its articles. Its main subfields are Public Health, Environmental and Occupational Health. (generated from OpenAlex topic counts and CAS ranking data)

Editor-in-Chief: Professor Qing Yi Transplant Research and Risk Management is an international, peer-reviewed, open access journal focusing on all aspects of transplantation and risk management to achieve optimal outcomes in the recipient improving survival and quality of life. Specific topics covered in the journal include: Screening and tissue matching, Cell biology, immunology and therapy, Experimental and clinical transplantation, Rejection management, optimal use of immunosuppressants and supportive drugs, Development of novel agents, techniques and procedures, Ethics and policy, Patient adherence and quality of life, Health economic evaluations and resource management. The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews and evaluations, guidelines, expert opinion and commentary, case reports and extended reports. Transplant Research and Risk Management will no longer consider meta-analyses for publication.

From the journal's Aims & Scope

Research area (LetPub): TRANSPLANTATION

Editor-in-chief Qing YiPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Renal Transplantation Outcomes and TreatmentsMedicine20.5%
  2. Organ Transplantation Techniques and OutcomesMedicine18.4%
  3. Organ Donation and TransplantationMedicine9%
  4. Transplantation: Methods and OutcomesMedicine8.4%
  5. Liver Disease and TransplantationMedicine4.2%
  6. Pharmacological Effects and Toxicity StudiesMedicine4.2%
  7. Polyomavirus and related diseasesMedicine3.7%
  8. Pregnancy and Medication ImpactMedicine3.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorTransplantationZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ScopusLetPub

Early warning / risk: Marked as ceased in ESCI on 16 February 2026. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
1LetPub ·
SJR 2026-06
0.21LetPub ·
SNIP 2026-06
0.91LetPub ·
h-index
11OpenAlex ·
i10-index
14OpenAlex ·
2-year mean citedness
1OpenAlex ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
2LetPub ·

Articles by year OpenAlex count · 92 in total · the current year is incomplete

YearArticlesOpen accessCitations
2024222
2023111
2022667
2021339

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 16 weeksLetPub ·
Peer review
Anonymous peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 1,806——
LetPubUSD 1,920Yes—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare4 items from the author guidelines
Reference style
Author–date
First submission
Free format: the journal's layout is not required
Graphical abstract
Optional
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted2
  1. case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
  2. reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Publisher website

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Dove Medical Press
Country or region
United Kingdom
Language
English
ISSN
1179-1616
Official links

FAQ

Frequently asked questions about Transplant Research and Risk Management

What CAS zone is Transplant Research and Risk Management in?

In the 2025 upgraded edition of the CAS Journal Ranking, Transplant Research and Risk Management is in Zone 4 of Medicine, and in Zone 4 of the minor category Transplantation. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Transplant Research and Risk Management?

Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Transplant Research and Risk Management?

According to the journal's author guidelines: Reference style: Author–date; First submission: Free format: the journal's layout is not required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Which databases index Transplant Research and Risk Management?

According to LetPub and DOAJ records, Transplant Research and Risk Management is indexed in Scopus.

Is Transplant Research and Risk Management open access, and what is the APC?

Transplant Research and Risk Management is a fully open-access journal. APC about USD 1,806.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .